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http:WHAT THIS PAPER ADDS
This study describes the inﬂuence of sclerosant concentration and liquid air fraction on foam stability, as well as
on the size and count of bubbles following sclerosant foam injection. This will allow clinicians to make an
informed decision about which concentration and liquid air fraction to use.Objectives: To determine the effects of sclerosant foam preparation and composition on foam structure, the time
course of liquid drainage, and foam coarsening.
Methods: Sodium tetradecyl sulphate (STS) and polidocanol (POL) foams were investigated in a range of
concentrations (0.5e3%) and liquid-plus-air fractions (LAF; 1 þ 2 to 1 þ 8). Foam was injected into a vein
simulation model (polyvinyl chloride tubing, inner diameter 3 mm, constant pressure 5e7 mmHg) ﬁlled with
saline or blood. Liquid drainage, bubble count, and diameter were measured and documented by serial
photography.
Results: Liquid drainage was faster in the vertical position than the horizontal one. In all variations, very small
bubbles (diameter <30 mm) were generated initially that coarsened to form micro-foams (<250 mm). By
3 minutes mini-foams (>250 mm) and by 7.5 minutes macro-foams (>500 mm) were formed. Following injection,
the upper regions of foam coarsened faster as liquid drained to the bottom of the vessel. Wet preparations
produced signiﬁcantly smaller bubbles. Low concentration POL foam produced signiﬁcantly higher bubble counts
and coarsened slower than STS.
Conclusions: Foam structure is strongly inﬂuenced by the LAF. Despite the initial formation of micro-bubbles in
the syringe, mini- and macro-bubbles are formed in target vessels with time post-injection.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Detergent sclerosants sodium tetradecyl sulphate (STS) and
polidocanol (POL) are surface active agents (surfactants)
used in liquid or foam format to disrupt the endothelial
lining of blood vessels with the ultimate aim of inducing
endovascular occlusion.1,2 Liquid sclerosants are heavily
deactivated by blood components; hence, foam formats are
preferred in the treatment of larger vessels owing to their
increased potency.3,4 The increased efﬁcacy of foam is
attributed to displacement of the intravascular blood and,
hence, a greater exposure of the endothelial lining to the
active agent.3e5responding author. K. Parsi, Dermatology, Phlebology and Fluid
nics Research Laboratory, St. Vincent’s Hospital Centre for Applied
l Research, Level 8, Lowy-Packer Building, 405 Liverpool Street,
hurst, NSW 2010, Australia.
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//dx.doi.org/10.1016/j.ejvs.2013.07.013Aqueous foams are dispersions of gas in liquid, stabilised
by surfactant adsorbed at the aireliquid interfaces.6
Aqueous foams are out-of-equilibrium systems that evolve
over time by gravitational drainage of liquid, coarsening,
and ﬁlm rupture. Foams coarsen because of pressure dif-
ferences between bubbles of different sizes resulting in an
increase of the mean bubble size. As aqueous foams
coarsen at the top, a dry front propagates down through
the foam and liquid emerges and accumulates at the bot-
tom. Foam stability, liquid drainage, and foam coarsening
are dependent on properties such as foam wetness, sur-
factant used, and bubble size.6
Sclerosant foams used in clinical practice are not stand-
ardised and are commonly generated using various tech-
niques at the patient’s bedside.5,7 A dual syringe system is
commonly used to generate foam by pumping a gas (such
as room air) and the liquid detergent through a three-way
stopcock. This study aimed to determine the effect of
sclerosant foam preparation and composition on foam
structure, and, in particular, the time course of liquid
drainage and foam coarsening.
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Deﬁnitions
Liquid drainage was deﬁned as the percentage volume of
liquid draining and separating from foam. Foam coarse-
ness was deﬁned using the diameter of bubbles as
micro-foam (<250 mm), mini-foam (250e500 mm), and
macro-foam (>500 mm).2 Coarser foams were those con-
taining larger bubble diameters. The liquid-plus-air frac-
tion (LAF) investigated in this study included 1 þ 2, 1 þ 3,
1 þ 4, and 1 þ 8. Reference foam of 1 þ 4 consisted of
one part liquid and four parts air. “Wet” and “dry” were
deﬁned in comparative terms to 1 þ 4. Hence, “wet”
foams were those containing less air (1 þ 2 and 1 þ 3),
while “dry” had a higher air component (1 þ 8). A higher
LAF implied a higher air component.Materials
Materials included STS (FIBRO-VEIN 3% w/v; Australasian
Medical and Scientiﬁc, NSW, Australia); POL (Aethox-
ysklerol 3% w/v, Chemische Fabrik Kreussler, Wiesbaden,
Germany); sodium chloride 0.9% w/v (normal saline [NS];
Baxter Healthcare, NSW, Australia); 1-mL luer-lock syringe
(Becton Dickinson, NJ, USA); 3-mL luer-slip syringe (Ter-
umo, NJ, USA); three-way stopcock (Becton Dickinson); 5-
mm Steriﬁx ﬁlter (B-Braun, Melsungen, Germany), 25-G
(0.260 mm bore) needles (Becton Dickinson); 3-mm (in-
ner diameter) polyvinyl chloride tubing (PVC) (Klein Inﬁl-
tration Tube, HK Surgical, CA, USA); and a Nikon D70s
digital camera with AF Micro-Nikkor 105-mm lens (Nikon,
Tokyo, Japan).Blood collection
Following informed consent, fresh donor whole blood was
collected in citrate tubes (Vacutainer, 0.105 M; Becton
Dickinson) from healthy volunteers taking no medications
or supplements.Sclerosant foam preparation
Liquid sclerosants were diluted with NS to achieve the
desired concentrations. Foam was generated using a
modiﬁed Tessari method.7 Brieﬂy, liquid sclerosant was
drawn up in the 1-mL syringe and air in the 3-mL syringe
to achieve the desired LAF. The two syringes were
then assembled using a three-way stopcock with a ﬁlter
placed on both syringes. Stopcock and ﬁlter assembly
dead-space always consisted of air at the start of
foam generation. The plungers were moved through 5e10
full strokes (see below) to disperse the air in liquid.
A stroke was deﬁned as a movement emptying and
re-ﬁlling the syringe initially ﬁlled with liquid. The as-
sembly was inverted once during foam preparation to
optimise the mixing of air with the liquid sclerosant. The
assembly of two ﬁlters and stopcock introduced a
0.35  0.05 mL dead-space. Reported LAFs assume no
dead-space.Experimental set-up
All experiments and foam preparations were performed at
ambient room temperature. Two sets of experiments were
performed.
Injection syringe. Liquid drainage from sclerosant foam
was measured in a 3-mL syringe to determine the effect
of orientation, sclerosant type, and concentration. Foam
preparations were allowed to rest in the syringe in either
a vertical or horizontal position for 110 seconds. Hori-
zontal syringes were then turned to the vertical position
and ﬁxed in place. This was to allow measuring the
liquid volume using markers on the syringe. Serial
photography was commenced for all syringes at 120 sec-
onds until no further drainage could be detected. The
percentage of liquid drained was calculated as the volume
of the liquid layer at a given time divided by the total
liquid volume.
Vein model. In a horizontal tube, images of foam were
taken to assess ﬂow behaviour and foam coarsening. The
effects of sclerosant type, concentration, and LAF were
determined. For these experiments, a vein model was
constructed using a 110-cm PVC tube of 3 mm inner
diameter, horizontal for 50 cm, with open elevated reser-
voirs positioned 30 cm from either edge. The tube was ﬁlled
with saline or blood with an outlet back pressure calculated
to be 5e7 mmHg (650e950 Pa). This pressure was selected
to mimic saphenous vein pressure at the ankle level when
supine.4
All foam combinations were injected 5e10 seconds after
preparation into the vein model at mid-point. The needle
tip was positioned just short of the base of the tube with
the bevel facing upwards. Plunger displacement drove the
foam into the tube (at consistent volumes indicated in the
text) within 2 seconds at an angle of 25 (5) from the
horizontal position. Between experiments the tube was
cleared of residual bubbles with alternating water/air
boluses.
Measurements
Overall foam behaviour. Overall foam behaviour and the
direction of ﬂow in the vein model were documented by
serial photography.
Bubble count, diameter, and the rate of foam coarsening.
Bubble count and bubble diameters were measured in the
vein model at time points indicated in the text in three 8-
mm-long regions in the upper half (1.5 mm high, i.e.,
3  12 mm2) of the foam as smaller bubbles in the lower
half resolved poorly. Mean bubble counts were compared
between sclerosants and either LAF or concentration.
Photography
Liquid drainage in the syringe and foam structure and
behaviour in the vein model were documented by serial
photography with a single pixel resolution of 0.015 mm
(focus and zoom). A 50-mm-long region of the vein model
Figure 2. Blood ingress for wet (1 þ 2) 3% foams. (a) The behav-
iour of 3% (1 þ 2) sodium tetradecyl sulphate foam at the
advancing edge, 2 minutes after injection of 1.5 mL of sclerosant
foam. Liquid drainage from foam is apparent in lighter red regions.
This drainage layer ﬂowed below the bulk of the foam to form a
lower liquid layer. Blood ingressed below the liquid layer at the
foam front. (b) Schematic representation showing foam spreading
2 minutes post-injection; Inset: schematic representation showing
foam (shaded), drained liquid (white), and blood (red).
490 E. Cameron et al.immediately anterior to the bevel was analysed. Imaging
was obtained with a Nikon D70s digital single-lens reﬂex
camera with AF Micro-Nikkor 105 mm lens ﬁxed at 400 mm
from the vein model.
Statistical analysis
Liquid drainage and largest consistent bubble diameter
were assessed by multiple regression analysis using the R
statistical computing package (v. 2.14.2; R-Project). Bubble
counts were compared using Student t test with a signiﬁ-
cance threshold of p < .05, against a 3% concentration,
1 þ 4 LAF, STS “reference” foam.
RESULTS
Liquid drainage
For all preparations, liquid drainage was initially decreased
for horizontally orientated syringes compared with the
vertical syringes (Fig. 1). However, after turning to the
vertical position, within 180 seconds the liquid drainage in
the horizontal syringes reached similar levels to the vertical
ones.
Overall foam behaviour
Following injection into the vein model, foam ﬂowed in
both directions from the point of entry and occluded the
full diameter of the vessel. Blood ingress commenced from
the foam fronts and progressed below the foam/liquid layer
resulting in the loss of the apparent initial occlusion. For the
wettest foams (1 þ 2), the full diameter of the vessel was
not initially occluded and liquid drainage resulted in for-
mation of a distinct lower liquid layer (Fig. 2).0 120 240 360
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Figure 1. The effect of syringe orientation on liquid drainage. Liquid d
syringe following foam generation. Vertically-orientated syringes (C
horizontal position was maintained for 110 seconds before the syringe
after 120 seconds (shown here at time 0). Note. STS ¼ sodium tetradBubble count, diameter, and the rate of foam coarsening
In general, higher bubble counts corresponded with smaller
bubble diameters. Immediately after the injection (Fig. 3),
all foam preparations resulted in the formation of very small
bubbles (30 mm) that coarsened to micro-bubbles
(<250 mm). Upper regions of the foam coarsened more
rapidly than lower regions. Mini-bubbles (250e500 mm)
ﬁrst became apparent in the upper regions by 3 minutes
(Fig. 3) and macro-bubbles (>500 mm) by 7.5 minutes.240 360 0 120 240 360
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rainage from foam was assessed based on the orientation of the
) were compared with horizontally-orientated syringes (B). The
was turned vertical for measurement. All measurements started
ecyl sulphate; POL ¼ polidocanol.
Figure 3. The time course of foam coarsening. Foam coarsening
with time is shown after injection of 1.5 mL of 3% (1 þ 4) sodium
tetradecyl sulphate (STS) or polidocanol (POL). Mini-bubbles
(250e500 mm) were apparent 3 minutes after injection, with a
wide distribution of bubble diameters. No differences between the
sclerosants are apparent. Larger bubbles focus at the top of the
tube over time. Foam appears dark as bubbles reﬂect dark walls of
experimental rig.
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foams coarsened faster than high concentration STS foams,
whereas, for POL, high-concentration foams coarsened
fastest (Fig. 4). When injected into blood, there was no
signiﬁcant difference between bubble diameters for 0.5%,
1.5%, and 3% STS; however, POL at 0.5% produced signiﬁ-
cantly smaller bubbles than 1.5% and 3% POL (Fig. 5a). The
decreased bubble diameter seen at 0.5% POL corresponded
to a signiﬁcantly increased bubble count (Fig. 5b).
The wettest preparations had a smaller bubble diameter
and coarsened more slowly, while the dry foams had lower
mean bubble counts and larger bubble diameter in all cases
(Fig. 5c, d). POL produced signiﬁcantly higher bubble counts
than STS for the wettest foams (1 þ 3).
DISCUSSION
In this study, we investigated the effect of sclerosant foam
preparation and composition on foam structure, the time
course of liquid drainage, and foam coarsening in a vein
simulation model constructed out of PVC tubing. Here we
report the signiﬁcant effect of foam wetness on liquid
drainage, the time course of foam coarsening, and bubble
diameter.
We assessed the effect of foam composition on liquid
drainage and showed that liquid drainage occurred
more slowly in horizontal syringes than in the vertical ones.
The delay in drainage for syringes stored horizontally isconsistent with previous foam drainage studies that predict
taller foams draining faster owing to the reduced capillary
effects.8,9 Drainage increases the coarsening rate and re-
sults in increasingly dry foam with height.6,8,9 Therefore,
once foam is generated, syringes should be kept in the
horizontal position to reduce liquid drainage and foam
coarsening.
Following the injection into the vein model, all prepara-
tions but the wettest foams (1 þ 2) appeared to occlude the
full diameter of the vessel initially. The wettest foams
demonstrated the smallest bubble diameters; hence, this
observation may indicate a trade-off between keeping
bubbles small while maintaining a stable occlusion of the
vessel with foam. In time, three layers of coarsened foam,
liquid, and blood were observed in the vein model with
blood ingress ﬂowing from each foam front below the
drained liquid layer. Equal blood ingress from both sides is
not unexpected as there was no pressure gradient across
the vessel. The separation into three layers reﬂects the
density of each layer, with air being the least dense and
foam staying at the top, and blood being the densest layer,
ingressing below the foam and liquid sclerosant layers. In a
recent study, we determined the density of the liquid and
foam sclerosants, and demonstrated a lower density for
foam sclerosants when compared with liquid agents and
blood.10
In this study, all preparations, irrespective of LAF or the
type or concentration of sclerosants foam, produced very
small bubbles (<30 mm) that coarsened to form micro-
foams (<250 mm). Mini-foams (250e500 mm) were
formed by 3 minutes and by 7.5 minutes macro-foams
(>500 mm) were formed. In general, smaller bubbles
were generated by wetter preparations, and smaller bubble
size correlated with a higher bubble count. Drier foams
coarsened faster resulting in a faster formation of macro-
bubbles. Bubble size increased with height in the coars-
ening foams to produce a size gradient, as a result of
drainage, with larger bubbles coarsening at the top and
smaller bubbles persisting at the bottom of the vessel.
The coarsening rate was initially faster for STS than POL,
but both agents arrived at similar means at 3 minutes.
Concentration inﬂuenced coarsening rates differently for
each sclerosant. The coarsening rate was slower at lower
POL but higher STS concentrations. Overall, the effect of
concentration was small, suggesting the 0.5e3% range is
well above the critical micellar concentrationdthe con-
centration above which surface tension is approximately
constant. Bubble diameter was smaller for wetter foams
initially and over time.
This study may have a number of practical implications.
Higher liquid content resulted in smaller bubbles and
allowed bubbles within the foam to move more easily.
Hence, LAFs of 1 þ 3 and 1 þ 4 are best optimised to
occlude larger vessels, while minimising bubble size. Clini-
cally, micro-bubbles are preferred to macro-bubbles, as
micro-foams increase the exposure of the endothelial lining
to the active agent.5 Furthermore, macro-bubbles are more
likely to occlude small cerebral arteries than micro-bubbles,
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Figure 4. The effect of liquid air fraction and sclerosant concentration on foam coarsening. The effect of liquid air fraction and sclerosant
concentration on bubble diameter was assessed for 3 minutes post injection of 1 mL of sodium tetradecyl sulphate (STS) and polidocanol
(POL) into the vein simulation model containing normal saline (n  3).
492 E. Cameron et al.resulting in gas embolism. Hence, the ideal sclerosant foam
should generate small bubbles that coarsen slowly and
absorb rapidly. Given the present ﬁndings, sclerosant foams
should be injected within 3 minutes of preparation to avoid
larger bubbles. Using micro-bubble preparations, however,
is not a safeguard against intravascular coarsening of the
injected foam. The clinical intravascular evolution of scle-
rosant foams and the ultimate fate of the injected bubbles
may not parallel these in vitro ﬁndings and should be
investigated in future clinical studies.
The choice of sclerosant and concentration inﬂuences the
bubble shape and size. In this study, high concentration
(3%) STS and low concentration (0.5%) POL produced
smaller bubbles that coarsened slowly, whereas low-
concentration (0.5%) STS and high-concentration (3%) POL
produced larger bubbles that coarsened rapidly. The bubble
size and shape (polyhedral vs. spherical), and the three-
dimensional structure of the aqueous foam varies accord-
ing to the sclerosant type and characteristics such as charge
and viscosity. In a recent study we have studied the rela-
tionship between viscosity and temperature variations to
foam structure and stability.10,11 Further studies are un-
derway to investigate the bubble shape and micro-structure
of sclerosant foams.The ingress of blood from the foam fronts and formation
of a mixed liquid blood layer would result in mixing, dilu-
tion, and deactivation of the sclerosant and a drop in the
ﬁnal concentration.3 This would have signiﬁcant clinical
relevance as lower concentrations are associated with a
procoagulant proﬁle,12 which has been clinically detectable
at the foam front.13 Therefore, wetter foams are least
suitable in achieving a stable occlusion in larger vessels. It
would be clinically prudent to reduce the diameter of larger
vessels before the administration of foam sclerosants. This
can be achieved by using methods such as inﬁltration of
tumescent ﬂuid in the perivascular space before the
administration of the sclerosing foam. Induction of
adequate venous spasm would, in particular, help the
wetter foams to be more occlusive and reduce the mixing
and deactivation at the foam front.
This study had several limitations. We investigated room
air as the foaming gas and used 1-mL/3-mL syringe com-
binations to generate the foam. Other gases, such as carbon
dioxide (CO2) or a combination of CO2/oxygen, as well as
other syringe combinations (e.g., 3-mL/5-mL; 5-mL/10-mL),
are also used in the clinical practice and should be inves-
tigated in future studies. A combination of higher resolution
imaging and image analysis techniques would be required
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Figure 5. Bubble count and diameter following foam injection. The effect of (a, b) sclerosant concentration and liquid air fraction (LAF) (c,
d) on mean bubble diameters (a, c) and bubble count (b, d) at 7.5 minutes for sodium tetradecyl sulphate (STS) and polidocanol (POL)
foams injected into a vein model ﬁlled with blood. The effect of sclerosant concentration was tested on LAF 1 þ 4, and the effects of LAF
was tested at 3% sclerosant concentration. Note. *p < .05, **p < .01, ***p < .001; n  3. NS ¼ not signiﬁcant.
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model used in this study had a ﬁxed diameter whereas real
vessels change size in response to temperature variations,
environmental factors, or vasoactive mediators and stimuli.
In conclusion, while it is known that injected foam is
composed of micro-bubbles, if this foam remains cohesive
for minutes then signiﬁcantly larger bubbles form. Foam
structure is strongly inﬂuenced by LAF. Higher liquid content
results in formation of micro-bubbles that coarsen slowly,
while higher gas content results in formation of dry foams
that coarsen more rapidly. The ingress of blood at the foam
front and liquid drainage from foam results in formation of
distinct layers of foam, liquid, and blood in the vessel.
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